AVP and posterior cortical atrophy: Androgen-deprivation treatment (ADH) is widely used in the treatment of prostate cancer (PCa) [1], and the longstanding concerns regarding testosterone and PCa has drove investigators to focus on the role in tumor development and the predictive value on prognosis [2, 3].